Folate, related vitamins and risk of Alzheimer's disease

Expert Review of Endocrinology and Metabolism

Volumn 2, Issue 5, 2007, Pages 559-561

  Luchsinger, José A ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE; PLACEBO; PYRIDOXINE;

AGING; ALZHEIMER DISEASE; BRAIN ATROPHY; CARDIOVASCULAR DISEASE; CEREAL; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CORRELATION ANALYSIS; CYANOCOBALAMIN DEFICIENCY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; EDITORIAL; FOLIC ACID DEFICIENCY; FOOD INTAKE; GENETIC RISK; HUMAN; MEDICAL RESEARCH; NERVE CELL LESION; NUTRITIONAL HEALTH; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PYRIDOXINE DEFICIENCY; RISK BENEFIT ANALYSIS; RISK FACTOR; STROKE; VITAMIN SUPPLEMENTATION;

EID: 34648836574     PISSN: 17446651     EISSN: None     Source Type: Journal    
DOI: 10.1586/17446651.2.5.559     Document Type: Editorial

References (24)

1. Cummings JL. Alzheimer's disease. N. Engl. J. Med. 351, 56-67 (2004).
2. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am. J. Public Health 88, 1337-1342 (1998).
3. Selkoe DJ. Alzheimer's disease: genotypes, phenotypes, and treatments. Science 275, 630-631 (1997).
4. Luchsinger J, Mayeux R. Cardiovascular risk factors and Alzheimer's disease. Curr Atheroscler. Rep. 6, 261-266 (2004).
5. Selkoe DJ. The origins of Alzheimer disease: a is for amyloid. JAMA 283, 1615-1617 (2000).
6. Luchsinger JA, Mayeux R. Dietary factors and Alzheimer's disease. Lancet Neurol. 3, 579-587 (2004).
7. Seshadri S, Beiser A, Selhub J et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346, 476-483 (2002).
8. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270, 2693-2698 (1993).
9. Rasmussen K, Moller J, Lyngbak M, Pedersen AM, Dybkjaer L. Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin. Chem. 42, 630-636 (1996).
10. Seshadri S, Wolf PA. Homocysteine and the brain: vascular risk factor or neurotoxin? Lancet Neurol. 2, 11 (2003).
11. Snowdon DA, Tully CL, Smith CD, Riley KP, Markesbery WR. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. Am. J. Din. Nutr. 71, 993-998 (2000).
12. Luchsinger JA, Tang MX, Shea S, Miller J, Green R, Mayeux R. Piasma homocysteine levels and risk of Alzheimer disease. Neurology 62, 1972-1976 (2004).
13. Haan MN, Miller JW, Aiello AE et al. Homocysteine, B vitamins, and the incidence of dementia and cognitive impairment: results from the Sacramento Area Latino Study on Aging. Am. J. Clin. Nutr. 85, 511-517 (2007).
14. Wang HX, Wahlin A, Basun H, Fastbom J, Winblad B, Fratiglioni L. Vitamin B(12) and folate in relation to the development of Alzheimeis disease. Neurology 56, 1188-1194 (2001).
15. Crystal HA, Ortof E, Frishman WH, Gruber A, Hershman D, Aronson M. Serum vitamin B 12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx Longitudinal Aging Study. J. Am Geriatr. Soc. 42, 933-936 (1994).
16. Morris MC, Evans DA, Schneider JA, Tangney CC, Bienias JL, Aggarwal NT. Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease. J. Alzheimers Dis. 9, 435-443 (2006).
17. Morris MC, Evans DA, Bienias JL et al. Dietary folate and vitamin B 12 intake and cognitive decline among community-dwelling older persons. Arch. Neurol. 62, 641-645 (2005).
18. Luchsinger JA, Tang MX, Miller J, Green R, Mayeux R. Relation of higher folate intake to lower risk of Alzheimer disease in the elderly. Arch. Neurol. 64, 86-92 (2007).
19. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N. Engl. J. Med. 340, 1449-1454 (1999).
20. Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst. Rev. 3, CD001056 (2001).
21. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am. J. Clin. Nutr. 85, 193-200 (2007).
22. Toole JF, Malinow MR, Chambless LE et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial Infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291, 565-575 (2004).
23. Wang X, Qin X, Demirtas H et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 369, 1876-1882 (2007).
24. McMahon JA, Green TJ, Skeaff CM, Knight RG, Mann JI, Williams SM. A controlled trial of homocysteine lowering and cognitive performance. N. Fngl. J. Med. 354, 2764-2772 (2006).